Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program

Cited by (1,002)

Items 101–200 of 1,002

1. Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies
   Claudia Maria Hattinger, Maria Pia Patrizio, Leonardo Fantoni, Chiara Casotti, Chiara Riganti, Massimo Serra · 2021 · Cancers
2. Survival in high-grade osteosarcoma: improvement over 21 years at a single institution
   Piero Picci, Marco Mercuri, Stefano Maria Ferrari, Marco Alberghini, A Briccoli, Cristina Ferrari, Elettra Pignotti, Giulia Bacci · 2009 · Annals of Oncology
3. The Adolescent and Young Adult with Cancer: State of the Art - Bone Tumors
   Nino Carlo Rainusso, Lisa L. Wang, Jason Todd Yustein · 2013 · Current Oncology Reports
4. Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
   Binghao Li, Zhan Wang, Hao Wu, Mingfeng Xue, Peng Lin, Shengdong Wang, Nong Lin, Xin Huang, Weibo Pan, Meng Liu et al. · 2018 · Cancer Research
5. Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance Study
   Alicia Gilsenan, Kirk D. Midkiff, David Harris, Nicole Kellier‐Steele, David McSorley, Elizabeth B. Andrews · 2020 · Journal of Bone and Mineral Research
6. High incidence of methotrexate associated renal toxicity in patients with lymphoma: a retrospective analysis
   Jori E. May, Kenneth Robert Carson, Sara K. Butler, Weijian Liu, Nancy L. Bartlett, Nina D. Wagner‐Johnston · 2013 · Leukemia & lymphoma/Leukemia and lymphoma
7. Molecular Distinction of Chondrosarcoma From Chondroblastic Osteosarcoma Through IDH1/2 Mutations
   Darcy A. Kerr, Hector U. Lopez, Vikram Deshpande, Francis John Hornicek, Zhenfeng Duan, Yaxia Zhang, Andrew Eric Rosenberg, Darrel R. Borger, G. Petur Nielsen · 2013 · The American Journal of Surgical Pathology
8. Osteosarcoma: improvement in survival limited to high-grade patients only
   Muhammad Umar Jawad, Michael C. Cheung, Jennifer Clarke, Leonidas G. Koniaris, Sean P. Scully · 2010 · Journal of Cancer Research and Clinical Oncology
9. Long non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326 and promotes tumorigenesis in osteosarcoma
   Jiandong Wang, Lei Cao, Jianhong Wu, Qiugen Wang · 2017 · International Journal of Oncology
10. HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival
    Koirala, Pratistha, Roth, Michael E., Gill, Jonathan, Chinai, Jordan M., Ewart, Michelle R., Piperdi, Sajida, Geller, David S., Hoang, Bang H., Fatakhova, Yekaterina V., Ghorpade, Maya et al. · 2016 · Scientific Reports
11. A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma
    Lisa J. Mirabello, Roelof Koster, Branden S. Moriarity, Logan G. Spector, Paul S. Meltzer, Joy M. Gary, Mitchell J. Machiela, Nathan Pankratz, Orestis A. Panagiotou, David A. Largaespada et al. · 2015 · Cancer Discovery
12. Primary Osteosarcoma in the Elderly Revisited: Current Concepts in Diagnosis and Treatment
    Rajendra Kumar, Meena Kumar, Kavin Malhotra, SHREYASKUMAR R. PATEL · 2018 · Current Oncology Reports
13. Mesenchymal stem cell transformation and sarcoma genesis
    Wei Xiao, Alexander B. Mohseny, Pancras C.W. Hogendoorn, Anne‐Marie Cleton-Jansen · 2013 · Clinical Sarcoma Research
14. miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells
    Yong Wang, Wei Zhao, Qin Fu · 2013 · Molecular and Cellular Biochemistry
15. Genome‐wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma
    Jan Smida, Hongen Xu, Yanping Zhang, Daniel Baumhoer, Sebastian Ribi, Michal B Kovac, Irene von Luettichau, Stefan Bielack, Valerie B. O’Leary, Christine Leib‐Mösch et al. · 2017 · International Journal of Cancer
16. Retracted: Long non‐coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR‐195‐5p
    Chao Yang, Ke Wu, Shan Wang, Guanghui Wei · 2018 · Journal of Cellular Biochemistry · Retracted
17. MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1
    Kang Han, Xiang Chen, Na Bian, Baoan Ma, Tong-Tao Yang, Chengkui Cai, Qingyu Fan, Yong Zhou, TingBao Zhao · 2015 · Oncotarget
18. Imaging Pediatric Bone Sarcomas
    Sue Creviston Kaste · 2011 · Radiologic Clinics of North America
19. Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression
    Hsin-Lin Cheng, Ming‐Ju Hsieh, Jia‐Sin Yang, Chiao‐Wen Lin, Ko-Haung Lue, Ko‐Hsiu Lu, Shun‐Fa Yang · 2016 · Oncotarget
20. MicroRNA-195: a review of its role in cancers
    Wanpeng Yu, Xiao Mei Liang, Xiangdong Li, Yuan Zhang, Zhenqing Sun, Ying Liu, Jianxun Wang · 2018 · OncoTargets and Therapy
21. Recent Advances in Nanotechnology-Based Diagnosis and Treatments of Human Osteosarcoma
    Mahmood Barani, Mahwash Mukhtar, Abbas Rahdar, Saman Sargazi, Sadanand Pandey, Misook Kang · 2021 · Biosensors
22. International trends in incidence of osteosarcoma (1988‐2012)
    Gabriela Accetta Rojas, Aubrey K. Hubbard, Brandon J. Diessner, Karina Braga Ribeiro, Logan G. Spector · 2021 · International Journal of Cancer
23. Cell surface receptor expression patterns in osteosarcoma
    Sheref E. Hassan, Mikhail Bekarev, Mimi Kim, Juan Lin, Sajida Piperdi, Richard Greg Gorlick, David S. Geller · 2011 · Cancer
24. Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway
    Gang Kong, Yunpeng Jiang, Xiujiang Sun, Zhilin Cao, Guodong Zhang, Zhongyuan Zhao, Yong Bo Zhao, Yu Qian, Gong Cheng · 2017 · Oncology Reports
25. Single-cell transcriptomics reveals the regulative roles of cancer associated fibroblasts in tumor immune microenvironment of recurrent osteosarcoma
    Xin Huang, Lutong Wang, Haoyu Guo, Weiyue Zhang, Zengwu Shao · 2022 · Theranostics
26. MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma
    Aaron L. Sarver, Venugopal Thayanithy, Milcah C. Scott, Anne‐Marie Cleton-Jansen, Pancras C.W. Hogendoorn, Jaime F. Modiano, Subbaya Subramanian · 2013 · Orphanet Journal of Rare Diseases
27. Hypoxia Promotes Migration and Induces CXCR4 Expression via HIF-1α Activation in Human Osteosarcoma
    Mingjun Guo, Chengkui Cai, Guangyi Zhao, Xiuchun Qiu, Haien Zhao, Qiong Ma, Liying Tian, Xue‐Lian Li, Yunsheng Hu, Bo Liao et al. · 2014 · PLoS ONE
28. Mechanisms of oxidative stress, apoptosis, and autophagy involved in graphene oxide nanomaterial anti-osteosarcoma effect
    Zhibing Tang, Lin Zhao, Zaixing Yang, Zhaohui Liu, Jia Li Gu, Bing Bai, Jinlian Liu, Jiaying Xu, Huilin Yang · 2018 · International Journal of Nanomedicine
29. Risk Factors for Development of Canine and Human Osteosarcoma: A Comparative Review
    Kelly M. Makielski, Lauren J. Mills, Aaron L. Sarver, Michael S. Henson, Logan G. Spector, Shruthi Naik, Jaime F. Modiano · 2019 · Veterinary Sciences
30. Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma
    Regan, Daniel P., Chow, Lyndah, Das, Sunetra, Haines, Laurel, Palmer, Eric, Kurihara, Jade N., Coy, Jonathan W., Mathias, Alissa, Thamm, Douglas H., Gustafson, Daniel L. et al. · 2022 · Clinical Cancer Research
31. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
    Fan Li, Lei Cao, Donghua Hang, Fang Wang, Qiugen Wang · 2015 · PubMed Central
32. Exploring the Antimicrobial, Anticancer, and Apoptosis Inducing Ability of Biofabricated Silver Nanoparticles Using Lagerstroemia speciosa Flower Buds against the Human Osteosarcoma (MG-63) Cell Line via Flow Cytometry
    Shashiraj Kariyellappa Nagaraja, Anil Hugar, Raju Suresh Kumar, Muthuraj Rudrappa, Meghashyama Prabhakara Bhat, Abdulrahman Ibrahim Almansour, Karthikeyan Perumal, Sreenivasa Nayaka · 2023 · Bioengineering
33. Survival disparities by Medicaid status
    Siran M. Koroukian, Paul M. Bakaki, Derek Raghavan · 2011 · Cancer
34. New insights into molecular and cellular mechanisms of zoledronate in human osteosarcoma
    Ko‐Hsiu Lu, Eric Wun-Hao Lu, Chiao‐Wen Lin, Jia‐Sin Yang, Shun-Fa Yang · 2020 · Pharmacology & Therapeutics
35. Crosstalk of the Wnt/β-Catenin Signaling Pathway in the Induction of Apoptosis on Cancer Cells
    Cristina Trejo‐Solís, Ángel Escamilla-Ramírez, Dolores Jiménez‐Farfán, Rosa Angélica Castillo‐Rodríguez, Athenea Flores‐Nájera, Arturo Cruz-Salgado · 2021 · Pharmaceuticals
36. Primary Bone Tumors: Epidemiologic Comparison of 9200 Patients Treated at Beijing Ji Shui Tan Hospital, Beijing, China, With 10 165 Patients at Mayo Clinic, Rochester, Minnesota
    Xiaohui Niu, Hairong Xu, Carrie Y. Inwards, Yuan Li, Yi Ding, George Douglas Letson, Marilyn M. Bui · 2015 · Archives of Pathology & Laboratory Medicine
37. Prognostic factors in pulmonary metastasized high‐grade osteosarcoma
    Emilie P. Buddingh, Jakob Anninga, Michel I.M. Versteegh, Antonïe H.M. Taminiau, Rudolph Maarten Egeler, Catherina S. P. van Rijswijk, Pancras C.W. Hogendoorn, Arjan C. Lankester, Hans A. J. Gelderblom · 2009 · Pediatric Blood & Cancer
38. Li–Fraumeni Syndrome
    Hernán Correa · 2016 · Journal of Pediatric Genetics
39. SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT–receptor complex
    S-J Zhao, Y-Q Jiang, N-W Xu, Qian Li, Qing Zhang, S-Y Wang, Jiong Li, Y-H Wang, YL Zhang, SH Jiang et al. · 2017 · Oncogene
40. Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma
    Jianhao Li, Benchen Rao, Jie Yang, Liwen Liu, Maoxin Huang, Xin Liu, Guangying Cui, Chao Li, Qicai Han, Hao Yang et al. · 2020 · Frontiers in Oncology
41. Recent Insights into Therapy Resistance in Osteosarcoma
    Zachary D. Prudowsky, Jason Todd Yustein · 2020 · Cancers
42. Lipid metabolism within the bone micro-environment is closely associated with bone metabolism in physiological and pathophysiological stages
    Bo Wang, Heng Wang, Yuancheng Li, Lei Song · 2022 · Lipids in Health and Disease
43. Chronic Recurrent Multifocal Osteomyelitis
    Patrícia Costa‐Reis, Kathleen E. Sullivan · 2013 · Journal of Clinical Immunology
44. Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors
    Chiara Ratti, Laura Botti, Valeria Cancila, Silvia Galvan, Ilaria Torselli, Cecilia Garofalo, Maria Cristina Manara, Lucia Bongiovanni, Cesare Fabio Valenti, Alessia Burocchi et al. · 2017 · Clinical Cancer Research
45. CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models
    Xu, Ji-Feng, Pan, Xiao-Hong, Zhang, Shui-Jun, Zhao, Chen, Qiu, Bin-Song, Gu, Hai-Feng, Hong, Jian-Fei, Cao, Li, Chen, Yu, Xia, Bing et al. · 2015 · Oncotarget
46. CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma
    Yan Gao, Yong Feng, Jacson K. Shen, Min Lin, Edwin Choy, Gregory Michael Cote, David C. Harmon, Henry J. Mankin, Francis John Hornicek, Zhenfeng Duan · 2015 · Scientific Reports
47. Proteomic Analysis of Exosomes and Exosome-Free Conditioned Media From Human Osteosarcoma Cell Lines Reveals Secretion of Proteins Related to Tumor Progression
    Sofía Jerez, Héctor Araya, Roman Thaler, M. Cristine Charlesworth, Remigio López‐Solís, Alexis M. Kalergis, Pablo F. Céspedes, Amel Dudakovic, Gary S. Stein, André J. van Wijnen et al. · 2016 · Journal of Cellular Biochemistry
48. MAPK/ERK Signaling in Osteosarcomas, Ewing Sarcomas and Chondrosarcomas: Therapeutic Implications and Future Directions
    Chandhanarat Chandhanayingyong, Yuhree Kim, J. Robert Staples, Cody Hahn, Francis Young‐In Lee · 2012 · Sarcoma
49. Prognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published Data
    Haiyong Ren, Lingling Sun, Hengyuan Li, Zhaoming Ye · 2015 · BioMed Research International
50. Dioscin inhibits the growth of human osteosarcoma by inducing G2/M‐phase arrest, apoptosis, and GSDME‐dependent cell death in vitro and in vivo
    Qiuyue Ding, Wenda Zhang, Cheng Cheng, Fengbo Mo, Lei Chen, Guangfu Peng, Xianyi Cai, Jinglong Wang, Shuhua Yang, Xianzhe Liu · 2019 · Journal of Cellular Physiology
51. MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells
    Ziqiang Zhu, Jinshan Tang, Jianqiang Wang, Gang Duan, Lei Zhou, Xiaoqing Zhou · 2016 · PLoS ONE
52. Tumor-Suppressing Effects of miR451 in Human Osteosarcoma
    Haidong Xu, Qiang Mei, Luxia Shi, Jiajia Lu, Jianning Zhao, Qiang Fu · 2013 · Cell Biochemistry and Biophysics
53. Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin
    Chao He, Jian Sun, Chao Liu, Yuhang Jiang, Yongqiang Hao · 2019 · Clinical Epigenetics
54. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
    Geoffroy Danieau, Sarah Morice, Françoise Rédiní, Franck Verrecchia, Bénédicte Brounais-Le Royer · 2019 · International Journal of Molecular Sciences
55. Circular RNA hsa-circ-0016347 promotes proliferation, invasion and metastasis of osteosarcoma cells
    Hao Jin, Xin Jin, Hong Zhang, Wenbo Wang · 2017 · Oncotarget
56. Osteosarcoma in patients below 25�years of age: An observational study of incidence, metastasis, treatment and outcomes
    Zhigang Nie, Hao Peng · 2018 · Oncology Letters
57. Pediatric solid tumor genomics and developmental pliancy
    Xiang 'Anthony' Chen, Alberto S. Pappo, Michael A. Dyer · 2015 · Oncogene
58. Immunologic Response to Tumor Ablation with Irreversible Electroporation
    Xiaoxiang Li, Kui Xu, Wei Li, Xiuchun Qiu, Baoan Ma, Qingyu Fan, Zhao Li · 2012 · PLoS ONE
59. Serum miR-195 is a diagnostic and prognostic marker for osteosarcoma
    Haikang Cai, Hui Zhao, Jie Tang, Haishan Wu · 2014 · Journal of Surgical Research
60. Small nucleolar RNA host gene 1: A new biomarker and therapeutic target for cancers
    Lining Huang, Xingming Jiang, Zhidong Wang, Xiangyu Zhong, Sheng Tai, Yunfu Cui · 2018 · Pathology - Research and Practice
61. Zinc oxide nanoparticles inhibit osteosarcoma metastasis by downregulating β-catenin via HIF-1α/BNIP3/LC3B-mediated mitophagy pathway
    Guanping He, Jing‐Jun Nie, Xiao Liu, Zihao Ding, Peng Luo, Yu Liu, Bowen Zhang, Renxian Wang, Xiaoguang Liu, Yong Hai et al. · 2022 · Bioactive Materials
62. IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis
    Gross, Amy C., Cam, Hakan, Phelps, Doris A., Saraf, Amanda J., Bid, Hemant K., Cam, Maren, London, Cheryl A., Winget, Sarah A., Arnold, Michael A., Brandolini, Laura et al. · 2018 · JCI Insight
63. microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN.
    Jian-Hua Mao, Rong-Ping Zhou, Ai-Fen Peng, Zhi-Li Liu, Shan-Hu Huang, Xin-Hua Long, Yong Shu · 2012 · Oncology Letters
64. Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma
    Chuangzhong Deng, Yanyang Xu, Jianchang Fu, Xiaojun Zhu, Hongmin Chen, Huaiyuan Xu, Gaoyuan Wang, YiJiang Song, Guohui Song, Jinchang Lu et al. · 2020 · Cancer Science
65. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
    Zhi-Zhong Tian, Xinjun Guo, Yongming Zhao, Yuan Fang · 2015 · PubMed Central
66. Monocytes, Macrophages, and Osteoclasts in Osteosarcoma
    Fergal C. Kelleher, Hazel O’Sullivan · 2017 · Journal of Adolescent and Young Adult Oncology
67. Long non-coding RNA HOXA11-AS functions as a competing endogenous RNA to regulate ROCK1 expression by sponging miR-124-3p in osteosarcoma
    Mingxing Cui, Jingyu Wang, Qingjiang Li, Junlei Zhang, Jinling Jia, Xinli Zhan · 2017 · Biomedicine & Pharmacotherapy
68. Cross‐species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma
    Wendy A. Allen‐Rhoades, Lyazat Kurenbekova, Laura Satterfield, Neha Parikh, Daniel G. Fuja, Ryan Lane Shuck, Nino Carlo Rainusso, Matteo Maria Trucco, Donald A. Barkauskas, Eunji Jo et al. · 2015 · Cancer Medicine
69. Outcome of Lower-Limb Preservation with an Expandable Endoprosthesis After Bone Tumor Resection in Children
    Eric R. Henderson, Andrew M. Pepper, German A. Marulanda, Odion T. Binitie, David Cheong, George Douglas Letson · 2012 · Journal of Bone and Joint Surgery
70. miR-29 Family Inhibits Resistance to Methotrexate and Promotes Cell Apoptosis by Targeting COL3A1 and MCL1 in Osteosarcoma
    Wei Xu, Zhikun Li, Xiaodong Zhu, Ruijun Xu, Youjia Xu · 2018 · Medical Science Monitor
71. Optimization of the chicken chorioallantoic membrane assay as reliable in vivo model for the analysis of osteosarcoma
    Pierre Kunz, Astrid Schenker, Heiner Sähr, Burkhard Lehner, Jörg Fellenberg · 2019 · PLoS ONE
72. METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma
    Hongbo Li, Gang Huang, Jian Tu, Dongming Lv, Qinglin Jin, Jun-Kai Chen, Yutong Zou, Dung‐Fang Lee, Jingnan Shen, Xianbiao Xie · 2022 · EBioMedicine
73. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT‐qPCR: Signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart
    Andrea Y. Angstadt, Alison A. Motsinger‐Reif, Rachael J. Thomas, William C. Kisseberth, C. Guillermo Couto, Dawn L. Duval, Dahlia M. Nielsen, Jaime F. Modiano, Matthew Breen · 2011 · Genes Chromosomes and Cancer
74. Degalactotigonin, a Natural Compound from Solanum nigrum L ., Inhibits Growth and Metastasis of Osteosarcoma through GSK3β Inactivation–Mediated Repression of the Hedgehog/Gli1 Pathway
    Zhiqiang Zhao, Qiang Jia, Man-Si Wu, Xianbiao Xie, Yongqian Wang, Guohui Song, Changye Zou, Qinglian Tang, Jinchang Lu, Gang Huang et al. · 2017 · Clinical Cancer Research
75. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway
    Weihai Liu, Zhiqiang Zhao, Yongqian Wang, Wuguo Li, Qiao Su, Qiang Jia, Jiajun Zhang, Xuelin Zhang, Jingnan Shen, Junqiang Yin · 2018 · Cell Death and Disease
76. A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model
    Goldstein, Seth D., Trucco, Matteo, Guzman, Wendy Bautista, Hayashi, Masanori, Loeb, David M. · 2016 · Oncotarget
77. microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells
    Masanori Kawano, Kazuhiro Tanaka, Ichiro Itonaga, Shinichi Ikeda, Tatsuya Iwasaki, Hiroshi Tsumura · 2015 · Journal of Experimental & Clinical Cancer Research
78. Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma
    Yidan Zhang, Yoav S. Zvi, Brian D. Batko, Nikolas H. Zaphiros, Edmond F. O’Donnell, Jichuan Wang, Kenji Satô, Rui Yang, David S. Geller, Pratistha Koirala et al. · 2018 · Scientific Reports
79. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma
    Xiubo Jiang, Zhenghao Zhang, Changqin Song, Hanzhi Deng, Runyu Yang, Lvqi Zhou, Yang Sun, Qi Zhang · 2019 · Chemico-Biological Interactions
80. Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: New insight to proliferation and metastasis
    Milad Ashrafizadeh, Mohammad Hossein Gholami, Sepideh Mirzaei, Amirhossein Zabolian, Amirabbas Haddadi, Mahdi Vasheghani Farahani, Sharareh Hosseinzadeh Kashani, Kiavash Hushmandi, Masoud Najafi, Ali Zarrabi et al. · 2021 · Life Sciences
81. International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines
    Simone de Campos Vieira Abib, Chan Hon Chui, Sharon Gail Cox, Abdelhafeez H. Abdelhafeez, Israel Fernández‐Pineda, Ahmed Elgendy, Jonathan Saul Karpelowsky, Pablo Andrés Lobos, Marc Wijnen, Jörg Fuchs et al. · 2022 · ecancermedicalscience
82. Copper-Loaded Nanoheterojunction Enables Superb Orthotopic Osteosarcoma Therapy via Oxidative Stress and Cell Cuproptosis
    Jiechao Xia, Chuan Hu, Yinwen Ji, Min Wang, Jin Yang, Lin Ye, Dingqi Xie, Sicheng Jiang, Renhong Li, Zhijun Hu et al. · 2023 · ACS Nano
83. Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients
    Ayşe Durnalı, Necati Alkış, Şengül Cangür, Fisun Ardıç Yükrük, Ali̇ İnal, Saadet Tokluoğlu, Mehmet Metin ŞEKER, Öznur Bal, Tülay Akman, Mevlüde İnanç et al. · 2013 · Medical Oncology
84. The Evolving Role of Proton Beam Therapy for Sarcomas
    Sabine Frisch, Beate Timmermann · 2017 · Clinical Oncology
85. Research models and mesenchymal/epithelial plasticity of osteosarcoma
    Xiaobin Yu, Jason Todd Yustein, Jianming Xu · 2021 · Cell & Bioscience
86. Twenty‐year outcome of prevalence, incidence, mortality and survival rate in patients with malignant bone tumors
    Yao Xu, Fanqi Shi, Yanting Zhang, Mengfan Yin, Xiuxin Han, Jinyan Feng, Guowen Wang · 2023 · International Journal of Cancer
87. Overexpression of Long Non-Coding RNA HOTAIR Promotes Tumor Growth and Metastasis in Human Osteosarcoma
    Bo Wang, Yun Su, Qun Yang, Decheng Lv, Weiguo Zhang, Kai Tang, Hong Wang, Rui Zhang, Yang Liu · 2015 · Molecules and Cells · Retracted
88. Analysis of the Expression of Repetitive DNA Elements in Osteosarcoma
    Xuan Dung Ho, hoang Gia Nguyen, Le Huy Trinh, Ene Reimann, Ele Prans, Gea Kõks, Katre Maasalu, Van Quang Le, Văn Hiếu Nguyễn, Nghi T. N. Le et al. · 2017 · Frontiers in Genetics
89. Effectiveness of 18F-FDG PET/CT in the diagnosis and staging of osteosarcoma: a meta-analysis of 26 studies
    Fanxiao Liu, Qingyu Zhang, Dongsheng Zhou, Jinlei Dong · 2019 · BMC Cancer
90. Predictive model for the 5-year survival status of osteosarcoma patients based on the SEER database and XGBoost algorithm
    Jiuzhou Jiang, Hao Pan, Mobai Li, Bao Qian, Xianfeng Lin, Shunwu Fan · 2021 · Scientific Reports
91. Mifamurtide in metastatic and recurrent osteosarcoma: A patient access study with pharmacokinetic, pharmacodynamic, and safety assessments
    Pete M. Anderson, Paul A. Meyers, Eugenie S. Kleinerman, Karthik Venkatakrishnan, Dennis P.M. Hughes, Cynthia E. Herzog, Winston W. Huh, Robert M. Sutphin, Yatin M. Vyas, Violet Shen et al. · 2013 · Pediatric Blood & Cancer
92. Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated‐Stat3 correlates with poor prognosis
    Keinosuke Ryu, Edwin Choy, Yang Cao, Michiro Susa, Francis John Hornicek, Henry J. Mankin, Zhenfeng Duan · 2010 · Journal of Orthopaedic Research®
93. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression
    Gang Li, Keyu Liu, Xinhui Du · 2018 · Yonsei Medical Journal
94. A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma
    the National Osteosarcoma Etiology Study Group, Lisa J. Mirabello, Kai F. Yu, Sonja I. Berndt, Laurie A. Burdett, Zhaoming Wang, Salma Chowdhury, Kedest Teshome, Arinze Uzoka, Amy A Hutchinson et al. · 2011 · BMC Cancer
95. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway
    Shu‐Feng Zhou, Ningkui Niu, Zi-Li Wang, Shuting Pan, Hui-Qiang Ding, Giang H. T. Au, Zhixue He, Zhi-Wei Zhou, Guozhi Xiao, Yinxue Yang et al. · 2015 · Drug Design Development and Therapy
96. Specific Small‐Molecule NIR‐II Fluorescence Imaging of Osteosarcoma and Lung Metastasis
    Hui Zhou, Wanrong Yi, Anguo Li, Bo Wang, Qihang Ding, Liru Xue, Xiaodong Zeng, Yanzhi Feng, Qianqian Li, Tian Wang et al. · 2019 · Advanced Healthcare Materials
97. Animal Models in Osteosarcoma
    María V. Guijarro, Steven C. Ghivizzani, C. Parker Gibbs · 2014 · Frontiers in Oncology
98. Overexpression of BMI-1 Promotes Cell Growth and Resistance to Cisplatin Treatment in Osteosarcoma
    Zhihong Wu, Li Min, Dafu Chen, Dongsheng Hao, Yuan‐Hui Duan, Guixing Qiu, Yipeng Wang · 2011 · PLoS ONE
99. Long-term functional outcomes and quality of life in adult survivors of childhood extremity sarcomas: a report from the St. Jude Lifetime Cohort Study
    Israel Fernández‐Pineda, Melissa Maria Hudson, Alberto S. Pappo, Michael William Bishop, James L. Klosky, Tara M. Brinkman, Deo Kumar Srivastava, Michael D. Neel, B. N. Rao, Andrew M. Davidoff et al. · 2016 · Journal of Cancer Survivorship
100. Naturally Occurring Cancers in Dogs: Insights for Translational Genetics and Medicine
     Carlos E. Alvarez · 2014 · ILAR Journal